Announced Fri, 26 Jun · 13:23 IST
Trading window closure for Q1 FY26 results - starts July 1, 2026
Compliance View source PDF
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹92.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.5-4.5-5.9-8.2-10.1-6.8-17.8———
Up moveDown movePending
AI summary
Aarey Drugs and Pharmaceuticals has informed BSE and NSE that the trading window for insiders, designated persons and their immediate relatives will remain closed from July 1, 2026, till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The closure is as per SEBI insider trading regulations. The board meeting date for approving Q1 results will be announced later.
Likely market impact
Routine compliance measure. No expected impact on stock price. Q1 results date to be intimated shortly.